TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
16 Novembre 2023 - 1:00PM
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical
technology company focused on providing innovative soft-tissue
reconstruction solutions that optimize clinical outcomes by
prioritizing the preservation and restoration of the patient's own
anatomy, today announced that the Company will participate in Piper
Sandler’s 35th Annual Healthcare Conference.
TELA’s management is scheduled to present at
Piper Sandler’s 35th Annual Healthcare Conference at 11:00 am ET on
November 30th, 2023. Interested parties can access the live and
archived webcast at ir.telabio.com.
About TELA Bio, Inc.TELA Bio,
Inc. (NASDAQ: TELA) is a commercial-stage medical technology
company focused on providing innovative technologies that optimize
clinical outcomes by prioritizing the preservation and restoration
of the patient's own anatomy. The Company is committed to providing
surgeons with advanced, economically effective soft-tissue
reconstruction solutions that leverage the patient's natural
healing response while minimizing long-term exposure to permanent
synthetic materials. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010ir@telabio.com
TELA Bio (NASDAQ:TELA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
TELA Bio (NASDAQ:TELA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024